From: Effects and Outcomes of Interferon Treatment in Japanese Hepatitis C Patients
Hepatitis C (n = 792) | Control (n = 1584) | Difference | |
---|---|---|---|
Male: Female | 512: 280 | 1024: 560 | matched |
Birth year −1929 | 320 | 640 | matched |
−1939 | 279 | 558 | matched |
1940- | 193 | 386 | matched |
Age at first visit (mean ± SD), years | 60.9 ± 12.3 | 60.9 ± 12.3 | matched |
LC at first visit | 177 (22.3%) | 8 (0.4%) | < 0.001 |
HCC at first visit | 45 (5.7%) | 2 (0.1%) | < 0.001 |
Liver biopsy/laparoscopy (F0–1 : F2 : F3 : F4) | 446 (56.3%) (182 : 83 : 42 : 139) | ||
IFN administration | 165 (20.8%) | 0 (0%) | |
SVR | 75 (45.5%) | ||
Non-SVR | 90 (54.5%) | ||
Outcomes Survival | 327 (41.3%) | 1031 (65.1%) | < 0.0001 |
Death | 400 (50.5%) | 482 (30.4%) | |
Unknown | 65 (8.2%) | 71 (4.5%) |